EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Assessing the impact of risk-based data monitoring on outcomes for a paediatric multicentre randomised controlled trial

Renate Le Marsney, Kerry Johnson iD, Jenipher Chumbes Flores, Shelley Coetzer, Jennifer Darvas, Carmel Delzoppo, Arielle Jolly, Kate Masterson iD, Claire Sherring, Hannah Thomson, Endrias Ergetu, Patricia Gilholm und 1 weitere

Clinical Trials · 2024

DOI: 10.1177/17407745231222019 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Trials, 2024. Verfasst von Renate Le Marsney und 12 weiteren Autor:innen. Beteiligte Einrichtung: Children's Intensive Care Research Program, Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: heartkids australia, Perth Children’s Hospital Foundation, national health and medical research council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims Regulatory guidelines recommend that sponsors develop a risk-based approach to monitoring clinical trials. However, there is a lack of evidence to guide the effective implementation of monitoring activities encompassed in this approach. The aim of this study was to assess the efficiency and impact of the risk-based monitoring approach used for a multicentre randomised controlled trial comparing treatments in paediatric patients undergoing cardiac bypass surgery.

Methods

This is a secondary analysis of data from a randomised controlled trial that implemented targeted source data verification as part of the risk-based monitoring approach. Monitoring duration and source to database error rates were calculated across the monitored trial dataset. The monitored and unmonitored trial dataset, and simulated trial datasets with differing degrees of source data verification and cohort sizes were compared for their effect on trial outcomes.

Results

In total, 106,749 critical data points across 1,282 participants were verified from source data either remotely or on-site during the trial. The total time spent monitoring was 365 hours, with a median (interquartile range) of 10 (7, 16) minutes per participant. An overall source to database error rate of 3.1% was found, and this did not differ between treatment groups. A low rate of error was found for all outcomes undergoing 100% source data verification, with the exception of two secondary outcomes with error rates >10%. Minimal variation in trial outcomes were found between the unmonitored and monitored datasets. Reduced degrees of source data verification and reduced cohort sizes assessed using simulated trial datasets had minimal impact on trial outcomes.

Conclusions

Targeted source data verification of data critical to trial outcomes, which carried with it a substantial time investment, did not have an impact on study outcomes in this trial. This evaluation of the cost-effectiveness of targeted source data verification contributes to the evidence-base regarding the context where reduced emphasis should be placed on source data verification as the foremost monitoring activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignChildHumansClinical Trials Data Monitoring CommitteesDatabases, FactualMulticenter Studies as TopicRandomized Controlled Trials as TopicRisk Assessment

Stichwörter der Autor:innen

Clinical trialdata qualitymonitoringquality assurancerisk-based monitoringsource data verificationtargeted monitoring

Autor:innen und Institutionen

  • Children's Intensive Care Research Program, Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia.
  • Paediatric Intensive Care Unit, Queensland Children's Hospital, Children's Health Queensland, Brisbane, QLD, Australia.
  • Paediatric Intensive Care Unit, Perth Children's Hospital, Perth, WA, Australia.
  • Paediatric Intensive Care Unit, Starship Child Health, Auckland, New Zealand.
  • Paediatric Intensive Care Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Paediatric Intensive Care Unit, Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.

ORCID-Profile: Kerry Johnson, Kate Masterson, Kristen S Gibbons

Förderung

  • heartkids australia
  • Perth Children’s Hospital Foundation
  • national health and medical research council
  • green lane research and educational fund

Zitieren

APA

Le Marsney, R., Johnson, K., Chumbes Flores, J., Coetzer, S., Darvas, J., Delzoppo, C., Jolly, A., Masterson, K., Sherring, C., Thomson, H., Ergetu, E., Gilholm, P., & Gibbons, K. S. (2024). Assessing the impact of risk-based data monitoring on outcomes for a paediatric multicentre randomised controlled trial. Clinical Trials. https://doi.org/10.1177/17407745231222019

Vancouver

Le Marsney R, Johnson K, Chumbes Flores J, Coetzer S, Darvas J, Delzoppo C, et al. Assessing the impact of risk-based data monitoring on outcomes for a paediatric multicentre randomised controlled trial. Clinical Trials. 2024. doi:10.1177/17407745231222019

BibTeX
@article{LeMarsney2024,
  author = {Le Marsney, Renate and Johnson, Kerry and Chumbes Flores, Jenipher and Coetzer, Shelley and Darvas, Jennifer and Delzoppo, Carmel and Jolly, Arielle and Masterson, Kate and Sherring, Claire and Thomson, Hannah and Ergetu, Endrias and Gilholm, Patricia and Gibbons, Kristen S},
  title = {Assessing the impact of risk-based data monitoring on outcomes for a paediatric multicentre randomised controlled trial},
  journal = {Clinical Trials},
  year = {2024},
  doi = {10.1177/17407745231222019}
}
Kostenlos starten →